Gene · 5004
Papers1,766
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,766
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Evaluation of serum cytokines and acute phase proteins as possible pharmacodynamic biomarkers to monitor endoscopic remission during ustekinumab therapy in patients with Crohn's disease. | Ther Adv Gastroenterol | 2023 | 37655059 | PubTator, text mining | PubMed |
| A diagnostic biomarker of acid glycoprotein 1 for distinguishing malignant from benign pulmonary lesions. | Int J Biol Markers | 2023 | 37654207 | PubTator, text mining | PubMed |
| Changes in plasma alpha-1 acid glycoprotein following hemorrhagic trauma: Possible role in dose differences of ALM drug therapy in rat and pig resuscitation. | Pharmacol Res Perspect | 2023 | 37643751 | PubTator, text mining | PubMed |
| Orosomucoid 1 promotes colorectal cancer progression and liver metastasis by affecting PI3K/AKT pathway and inducing macrophage M2 polarization. | Sci Rep | 2023 | 37640741 | PubTator, text mining | PubMed |
| Screening of Exosome-Derived Proteins and Their Potential as Biomarkers in Diagnostic and Prognostic for Pancreatic Cancer. | Int J Mol Sci | 2023 | 37628784 | PubTator, text mining | PubMed |
| Diagnosis of Paediatric Obstructive Sleep-Disordered Breathing beyond Polysomnography. | Children (Basel) | 2023 | 37628330 | PubTator, text mining | PubMed |
| Proteomic Analysis on Sequential Samples of Cystic Fluid Obtained from Human Brain Tumors. | Cancers (Basel) | 2023 | 37627098 | PubTator, text mining | PubMed |
| Biomarkers or biotargets? Using competition to lure cancer cells into evolutionary traps. | Evol Med Public Health | 2023 | 37599857 | PubTator, text mining | PubMed |
| Diagnostic and Prognostic Value of Protein Post-translational Modifications in Hepatocellular Carcinoma. | J Clin Transl Hepatol | 2023 | 37577238 | PubTator, text mining | PubMed |
| Proteomics of Plasma and Plasma-Treated Podocytes: Application to Focal and Segmental Glomerulosclerosis. | Int J Mol Sci | 2023 | 37569500 | PubTator, text mining | PubMed |
| The Latest Developments in Using Proteomic Biomarkers from Urine and Serum for Non-Invasive Disease Diagnosis and Prognosis. | Biomark Insights | 2023 | 37528936 | PubTator, text mining | PubMed |
| MIF is a critical regulator of mononuclear phagocytic infiltration in hepatocellular carcinoma. | iScience | 2023 | 37520719 | PubTator, text mining | PubMed |
| Impact of infection on proteome-wide glycosylation revealed by distinct signatures for bacterial and viral pathogens. | iScience | 2023 | 37520696 | PubTator, text mining | PubMed |
| Proteomic analysis identifies subgroups of patients with active systemic lupus erythematosus. | Clin Proteomics | 2023 | 37516862 | PubTator, text mining | PubMed |
| Integrating Proteomics and Lipidomics for Evaluating the Risk of Breast Cancer Progression: A Pilot Study. | Biomedicines | 2023 | 37509426 | PubTator, text mining | PubMed |
| Cutaneous immune-related adverse events to immune checkpoint inhibitors: from underlying immunological mechanisms to multi-omics prediction. | Front Immunol | 2023 | 37497220 | PubTator, text mining | PubMed |
| ER-localized Shr3 is a selective co-translational folding chaperone necessary for amino acid permease biogenesis. | J Cell Biol | 2023 | 37477900 | PubTator, text mining | PubMed |
| The 27th Scientific Conference of the Society on NeuroImmune Pharmacology: New Delhi, India, March 15-18, 2023. | NeuroImmune Pharm Ther | 2023 | 37476290 | PubTator, text mining | PubMed |
| Extracellular Vesicle Size Reveals Cargo Specific to Coagulation and Inflammation in Pediatric and Adult Sickle Cell Disease. | Clin Appl Thromb Hemost | 2023 | 37469147 | PubTator, text mining | PubMed |
| Proteogenomics of clear cell renal cell carcinoma response to tyrosine kinase inhibitor. | Nat Commun | 2023 | 37460463 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5004/papers?page=9